REDAELLI, SARA

REDAELLI, SARA  

DIPARTIMENTO DI MEDICINA E CHIRURGIA (SCHOOL OF MEDICINE AND SURGERY)  

Mostra records
Risultati 1 - 20 di 50 (tempo di esecuzione: 0.022 secondi).
Titolo Tipologia Data di pubblicazione Autori File
Volatile Sedation for Acute Respiratory Distress Syndrome Patients on Venovenous Extracorporeal Membrane Oxygenation and Ultraprotective Ventilation 01 - Articolo su rivista 2021 Grasselli, GiacomoGiani, MarcoScaravilli, VittorioMariani, CarminiaRedaelli, SaraLucchini, AlbertoZanella, AlbertoPatroniti, NicolòPesenti, AntonioFoti, Giuseppe +
Dual kinase targeting in leukemia 01 - Articolo su rivista 2021 Mologni L.Redaelli S. +
Synergistic drug combinations prevent resistance in ALK+ anaplastic large cell lymphoma 01 - Articolo su rivista 2021 Sharma, GGVilla, MMauri, MCrespiatico, IFontana, DMastini, CMagistroni, VCeccon, MRedaelli, SMassimino, LPiazza, RGambacorti Passerini, CMologni, L +
Integrated Genomic, Functional, and Prognostic Characterization of Atypical Chronic Myeloid Leukemia 01 - Articolo su rivista 2020 Fontana, DilettaRamazzotti, DanieleAroldi, AndreaRedaelli, SaraMagistroni, VeraPirola, AlessandraMassimino, LucaMastini, CristinaBombelli, SilviaElli, Elena MariaFumagalli, MonicaPerego, Roberto APagni, FabioMologni, LucaPiazza, RoccoGambacorti-Passerini, Carlo +
De novo UBE2A mutations are recurrently acquired during chronic myeloid leukemia progression and interfere with myeloid differentiation pathways 01 - Articolo su rivista 2019 Magistroni, VMauri, MD'Aliberti, DCrespiatico, IFontana, DSharma, NPirola, ARedaelli, SMassimino, LKhandelwal, PCitterio, SViltadi, MBombelli, SRigolio, RPerego, RGambacorti Passerini, CPiazza, R +
Abstract 902: In vitro andin vivocharacterization of resistance to lorlatinib treatment in ALK mutated cancers 02 - Intervento a convegno 2018 GEETA, GEETARedaelli, SCeccon, MGambacorti-Passerini, CMologni, L +
Lorlatinib treatment elicits multiple on- and off-target mechanisms of resistance in ALK-driven cancer 01 - Articolo su rivista 2018 Redaelli, SaraCeccon, MonicaSharma, Geeta GMastini, CristinaMauri, MarioMassimino, LucaCordani, NicolettaFarina, FrancescaPiazza, RoccoGambacorti-Passerini, CarloMologni, Luca +
SETBP1 induces transcription of a network of development genes by acting as an epigenetic hub 01 - Articolo su rivista 2018 Piazza, RoccoMagistroni, VeraRedaelli, SaraMauri, MarioMassimino, LucaPeronaci, MarcoPirola, AlessandraGambacorti-Passerini, Carlo +
Novel targeted therapeutics for MEN2 01 - Articolo su rivista 2018 Redaelli, SaraMologni, Luca +
Synergistic activity of ALK and mTOR inhibitors for the treatment of NPM-ALK positive lymphoma 01 - Articolo su rivista 2016 REDAELLI, SARACECCON, MONICAANTOLINI, LAURARIGOLIO, ROBERTAPIROLA, ALESSANDRAPERONACI, MARCOGAMBACORTI PASSERINI, CARLOMOLOGNI, LUCA
ETNK1 is an early event and SETBP1 a late event in atypical Chronic Myeloid Leukemia 02 - Intervento a convegno 2015 Piazza, RPirola, ADonadoni, CFontana, DRedaelli, SFarina, FGambacorti-Passerini, C +
Clonal evolution analysis identifies ETNK1 as an early event and SETBP1 as a late event in atypical Chronic Myeloid Leukemia 02 - Intervento a convegno 2015 Piazza, RPirola, ADonadoni, CFontana, DRedaelli, SGambacorti-Passerini, C +
Age and dPCR can predict relapse in CML patients who discontinued imatinib: The ISAV study 01 - Articolo su rivista 2015 MORI, SILVIALuciani, MREDAELLI, SARAPIROLA, ALESSANDRAPIAZZA, ROCCO GIOVANNIGAMBACORTI PASSERINI, CARLO +
Synergistic Activity of ALK and mTOR Inhibitors for the Treatment of NPM-ALK Positive Lymphoma 02 - Intervento a convegno 2015 Redaelli, SCeccon, MPirola, APeronaci, MGambacorti-Passerini, CMologni, L
Recurrent ETNK1 mutations in atypical chronic myeloid leukemia 01 - Articolo su rivista 2015 GAMBACORTI PASSERINI, CARLODONADONI, CARLAPIROLA, ALESSANDRAREDAELLI, SARAFONTANA, DILETTASPINELLI, ROBERTAMAGISTRONI, VERAPERONACI, MARCOPIAZZA, ROCCO GIOVANNI +
Non genomic loss of function of tumor suppressors in CML: BCR-ABL promotes IκBa mediated p53 nuclear exclusion 01 - Articolo su rivista 2015 Piazza, RRedaelli, S +
In vitro and in vivo identification of ABCB1 as an efflux transporter of bosutinib 01 - Articolo su rivista 2015 REDAELLI, SARAPERINI, PIETROCECCON, MONICAPIAZZA, ROCCO GIOVANNIRIGOLIO, ROBERTAMAURI, MARIOGAMBACORTI PASSERINI, CARLO +
Recurrent KIT D816V Mutation in Atypical Chronic Myeloid Leukemia 02 - Intervento a convegno 2014 REDAELLI, SARAPIAZZA, ROCCO GIOVANNIPIROLA, ALESSANDRAMAGISTRONI, VERAGAMBACORTI PASSERINI, CARLO +
In Vitro and in Vivo Characterization of Bosutinib as Substrate of the Pglycoprotein Efflux Transporter 02 - Intervento a convegno 2014 REDAELLI, SARAPERINI, PIETROCECCON, MONICAPIAZZA, ROCCO GIOVANNIRIGOLIO, ROBERTAGAMBACORTI PASSERINI, CARLO +
Evidence of ETNK1 Somatic Variants in Atypical Chronic Myeloid Leukemia 02 - Intervento a convegno 2014 DONADONI, CARLAPIAZZA, ROCCO GIOVANNIFONTANA, DILETTAPIROLA, ALESSANDRAREDAELLI, SARASPINELLI, ROBERTAMAGISTRONI, VERAGAIPA, GIUSEPPEPERONACI, MARCOELLI, ELENA MARIAGAMBACORTI PASSERINI, CARLO +